Author: Scott Welch
Many Republicans were quick to criticize House Speaker Nancy Pelosi’s new proposal to reduce drug prices. President Trump wasn’t one of them. Soon after the California Democrat released her drug-price bill Thursday, Trump said in a tweet that it was “great to see Speaker Pelosi’s bill.”
Worried drugmakers are stepping up efforts to blunt proposals in Washington that they view as some of the most serious threats to their pricing power in recent years.
Sen. Elizabeth Warren (D-Mass.) is coming under increasing pressure from her 2020 rivals to spell out how she’d pay for her “Medicare for All” proposal.
Most everyone who heard Gov. Gavin Newsom’s words had the same reaction: He’s finally on board.
The launch of President Barack Obama’s Affordable Care Act (ACA) was marred by the performance of the newly created state health insurance marketplaces.
The House Education and Labor Committee has called off plans to vote on legislation this week to protect patients from "surprise" medical bills because of divisions among lawmakers on the panel, according to House aides and lobbyists.
House Speaker Nancy Pelosi, D-Calif., unveiled her long-anticipated plan to lower the cost of prescription drugs on Thursday. It is a priority shared by President Trump, fueling a glimmer of hope that there is a deal to be had on the issue ahead of the 2020 elections.
A leaked draft of a Democratic plan for the government to negotiate drug prices, curbing surprise billing, and billions of healthcare funds ready to expire: Congress returned from an extended summer break with high stakes for its legislative sprint to the end of the year.
Nearly 8 in 10 Americans support legislation to protect people from surprise medical bills, a new poll from the Kaiser Family Foundation shows. That support persisted no matter which party was asked: 84% of Democrats, 78% of independents and 71% of Republicans said they support surprise billing legislation, according to the poll.
Members of Congress raked in almost $4 million from pharmaceutical manufacturers and their trade groups in the first six months of 2019. Two members — Sen. Chris Coons (D-Del.) and Sen. Thom Tillis (R-N.C.) — each received over $100,000.